Challenges in the pharmacovigilance of oncolytic drugs

被引:0
|
作者
Meyboom, RHB [1 ]
机构
[1] WHO Collaborating Ctr Int Drug Monitoring, Uppsala Monitoring Ctr, Uppsala, Sweden
关键词
D O I
暂无
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
2
引用
收藏
页码:929 / 929
页数:1
相关论文
共 50 条
  • [1] Challenges in pharmacovigilance
    Dikshit, R. K.
    [J]. INDIAN JOURNAL OF PHARMACOLOGY, 2010, 42 (06) : 333 - 333
  • [2] ONCOLYTIC DRUGS
    不详
    [J]. DRUG NEWS & PERSPECTIVES, 2010, 23 (03) : 196 - 196
  • [3] Oncolytic drugs
    不详
    [J]. DRUG NEWS & PERSPECTIVES, 2008, 21 (10) : 567 - 569
  • [4] Oncolytic drugs
    不详
    [J]. DRUG NEWS & PERSPECTIVES, 2004, 17 (03) : 202 - 203
  • [5] Pharmacovigilance for veterinary drugs
    Müntener, CR
    Gassner, B
    Demuth, DC
    Althaus, FR
    Zwahlen, R
    [J]. SCHWEIZER ARCHIV FUR TIERHEILKUNDE, 2004, 146 (11): : 499 - 505
  • [6] PHARMACOVIGILANCE OF ANTIHYPERTENSIVE DRUGS
    HUGUES, FC
    DELLAS, JA
    MARCHE, J
    [J]. THERAPIE, 1982, 37 (02): : 197 - 206
  • [7] Ongoing Challenges in Pharmacovigilance
    Gerald J. Dal Pan
    [J]. Drug Safety, 2014, 37 : 1 - 8
  • [8] Challenges of Pharmacovigilance in the Neonate
    Convertino, I.
    Sansone, A. Capogrosso
    Marino, A.
    Galiulo, M. T.
    [J]. DRUG SAFETY, 2016, 39 (10) : 1010 - 1010
  • [9] Ongoing Challenges in Pharmacovigilance
    Dal Pan, Gerald J.
    [J]. DRUG SAFETY, 2014, 37 (01) : 1 - 8
  • [10] Pharmacovigilance: The new challenges
    Bagheri, Haleh
    Laroche, Marie-Laure
    Montastruc, Jean-Louis
    [J]. THERAPIE, 2016, 71 (02): : 121 - 122